title: [Recommendations for inhaled nitric oxide treatment in the newborn].
abstract: The recommendations in this document describe the current indications for inhaled nitric oxide (iNO) treatment in the newborn and clearly distinguish between those supported by scientific evidence and those for which evidence is still lacking, such as its use in preterm infants. The methodology for iNO administration, its dosage and the main secondary effects are discussed, and the reasons for lack of response to this treatment are analyzed.
authors.affiliation: Hospital Clínico, Instituto Clínico de Ginecología, Obstetricia y Neonatología, Unidad Integrada de Pediatría, Universidad de Barcelona, Spain. jfiguer@clinic.ub.es
authors.forename: J
authors.initials: J
authors.lastname: Figueras Aloy
authors.forename: F
authors.initials: F
authors.lastname: Castillo Salinas
authors.forename: D
authors.initials: D
authors.lastname: Elorza Fernández
authors.forename: M
authors.initials: M
authors.lastname: Sánchez-Luna
authors.forename: J
authors.initials: J
authors.lastname: Pérez Rodríguez
mesh_terms: D000280:Administration, Inhalation; D045462:Endothelium-Dependent Relaxing Factors / Q000008:administration & dosage; D006330:Heart Defects, Congenital; D065630:Hernias, Diaphragmatic, Congenital; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000628:therapy*; D007234:Infant, Premature; D009569:Nitric Oxide / Q000008:administration & dosage*; D010547:Persistent Fetal Circulation Syndrome; D012127:Respiratory Distress Syndrome, Newborn
chemical_list: D045462:Endothelium-Dependent Relaxing Factors; D009569:Nitric Oxide